349 related articles for article (PubMed ID: 26585986)
1. Diagnosis and New Treatment Modalities for Glioblastoma: Do They Improve Patient Survival?
Alcedo-Guardia R; Labat E; Blas-Boria D; Vivas-Mejia PE
Curr Mol Med; 2016 Apr; ():. PubMed ID: 26585986
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier.
Frederico SC; Darling C; Bielanin JP; Dubinsky AC; Zhang X; Hadjipanayis CG; Kohanbash G
Front Immunol; 2023; 14():1057567. PubMed ID: 36875096
[TBL] [Abstract][Full Text] [Related]
4. Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma.
Tehrani M; Friedman TM; Olson JJ; Brat DJ
Brain Pathol; 2008 Apr; 18(2):164-71. PubMed ID: 18093251
[TBL] [Abstract][Full Text] [Related]
5. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas.
Christians A; Adel-Horowski A; Banan R; Lehmann U; Bartels S; Behling F; Barrantes-Freer A; Stadelmann C; Rohde V; Stockhammer F; Hartmann C
Acta Neuropathol Commun; 2019 Oct; 7(1):156. PubMed ID: 31623667
[TBL] [Abstract][Full Text] [Related]
7. Beyond grade: molecular pathology of malignant gliomas.
Sulman EP; Guerrero M; Aldape K
Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
[TBL] [Abstract][Full Text] [Related]
8. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
10. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.
McGirt MJ; Goldstein IM; Chaichana KL; Tobias ME; Kothbauer KF; Jallo GI
Neurosurgery; 2008 Jul; 63(1):55-60; discussion 60-1. PubMed ID: 18728568
[TBL] [Abstract][Full Text] [Related]
11. Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier.
Sharma RK; Calderon C; Vivas-Mejia PE
Front Med Technol; 2021; 3():678593. PubMed ID: 35047931
[TBL] [Abstract][Full Text] [Related]
12. Malignant gliomas.
Burton EC; Prados MD
Curr Treat Options Oncol; 2000 Dec; 1(5):459-68. PubMed ID: 12057153
[TBL] [Abstract][Full Text] [Related]
13. Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance.
Stoyanov GS; Lyutfi E; Georgieva R; Georgiev R; Dzhenkov DL; Petkova L; Ivanov BD; Kaprelyan A; Ghenev P
Cureus; 2022 Feb; 14(2):e21822. PubMed ID: 35291535
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
de Paula LB; Primo FL; Tedesco AC
Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholine Receptor Activation as a Modulator of Glioblastoma Invasion.
Thompson EG; Sontheimer H
Cells; 2019 Oct; 8(10):. PubMed ID: 31590360
[TBL] [Abstract][Full Text] [Related]
16. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms regulating glioma invasion.
Paw I; Carpenter RC; Watabe K; Debinski W; Lo HW
Cancer Lett; 2015 Jun; 362(1):1-7. PubMed ID: 25796440
[TBL] [Abstract][Full Text] [Related]
18. Management, outcomes, and prognostic factors of adult primary spinal cord gliomas.
Haque W; Verma V; Barber S; Tremont IW; Brian Butler E; Teh BS
J Clin Neurosci; 2021 Feb; 84():8-14. PubMed ID: 33485604
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy for Treatment of Brain Tumors (HSV-tKIn Vivo Gene Transfer) : A Case Study.
Weber F; Floeth F; Bojar H
Methods Mol Med; 2000; 35():499-509. PubMed ID: 21390826
[TBL] [Abstract][Full Text] [Related]
20. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
